Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 3, Pages 1084-1089
Publisher
Proceedings of the National Academy of Sciences
Online
2014-01-07
DOI
10.1073/pnas.1323102111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Agonists of luteinizing hormone-releasing hormone in prostate cancer
- (2013) Ferenc G Rick et al. EXPERT OPINION ON PHARMACOTHERAPY
- Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation
- (2013) James P. Dean et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts
- (2013) C. D. Fahrenholtz et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia
- (2013) Ferenc G. Rick et al. PROSTATE
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase II Pharmacodynamic Study of Preoperative Figitumumab in Patients with Localized Prostate Cancer
- (2012) K. N. Chi et al. CLINICAL CANCER RESEARCH
- Hormonal manipulation of benign prostatic hyperplasia
- (2012) Ferenc G. Rick et al. CURRENT OPINION IN UROLOGY
- Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival
- (2012) Stephanie O. Peacock et al. MOLECULAR ENDOCRINOLOGY
- Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases
- (2012) F. G. Rick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth Hormone-Releasing Hormone Receptor Splice Variant 1 is Frequently Expressed in Oral Squamous Cell Carcinomas
- (2012) Nikolina Dioufa et al. Hormones & Cancer
- Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers
- (2011) Anna Klukovits et al. CANCER
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
- (2011) P. J. Beltran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer
- (2011) S Rao et al. ONCOGENE
- Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia
- (2011) Ferenc G. Rick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins
- (2011) Anton Stangelberger et al. PROSTATE
- AMG 479, a Novel IGF-1-R Antibody, Inhibits Endometrial Cancer Cell Proliferation Through Disruption of the PI3K/Akt and MAPK Pathways
- (2011) Albert Mendivil et al. Reproductive Sciences
- Growth hormone-releasing hormone: not only a neurohormone
- (2011) Hippokratis Kiaris et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- The effect of GHRH antagonists on human glioblastomas and their mechanism of action
- (2010) Eva Pozsgai et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic Subunits
- (2010) Xinnong Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A correlation of endocrine and anticancer effects of some antagonists of GHRH
- (2010) Magdolna Kovács et al. PEPTIDES
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia
- (2010) Ferenc G. Rick et al. PROSTATE
- Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
- (2010) Jian Guo et al. Reproductive Biology and Endocrinology
- Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor
- (2009) Nektarios Barabutis et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- New Approaches to the Therapy of Various Tumors Based on Peptide Analogues
- (2008) A. Schally HORMONE AND METABOLIC RESEARCH
- Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138
- (2008) Elmar Heinrich et al. PROSTATE
- Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer
- (2007) Andrew V Schally et al. Nature clinical practice. Endocrinology & metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search